Pfizer establishes a $23.5 million R&D Centre in Chile

Pfizer and CORFO Chile

WAVTEQ, working with ICA, was awarded a contract by CORFO Chile, the national economic development agency of Chile, to attract US R&D investment to Chile and to promote to investors a new $70 million R&D incentives program.

WAVTEQ developed the R&D value proposition for Chile (a PPT presentation) and an introductory letter to use with investors.

Our team were fully briefed in the new R&D incentives policy and we identified the 60 largest R&D spending companies in the US in target sectors.

In each company we identified key decision makers for both R&D (e.g. SVP technology) and for Latin America (e.g. SVP, Latin America) and directly engaged with decision makers using social media, email and telephone.

For opportunities identified, we coordinated closely with CORFO to prepare responses for investors and set-up initial calls with CORFO.

The lead generation campaign was very successful, with three companies announcing operations in Chile within 12 months of the completion of the project.

As well as the Pfizer project, Emerson announced a 70 person Centre of Excellence in Chile.